Clinical trial
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
NCT00169559 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00169559 |
|---|---|
| Title | Dyslipidemia Study Investigating The Increase In "Good Cholesterol" |
| Official title | A Multi-center, Three-staged, Randomized, Parallel Group, Sequential, Double-blind, fenofibrate-and Placebo-controlled Dose-response Evaluation of the Safety, Tolerability, and Effects on Plasma HDLc and TG of Eight Weeks Treatment With 1µg to 20µg Daily Doses of GW590735 in Otherwise Healthy… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dyslipidaemias |
| Intervention type | Drug |
| Interventions | GW590735, fenofibrate |
| Enrollment | 250 |
| Start date | Nov 1, 2003 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 22, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: